000 01434 a2200385 4500
005 20250517135946.0
264 0 _c20170623
008 201706s 0 0 eng d
022 _a1439-7633
024 7 _a10.1002/cbic.201600652
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarsoner, Theodor
245 0 0 _aDNA-Targeted Inhibition of MGMT.
_h[electronic resource]
260 _bChembiochem : a European journal of chemical biology
_c05 2017
300 _a894-898 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents, Alkylating
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aDNA
_xmetabolism
650 0 4 _aDNA Modification Methylases
_xantagonists & inhibitors
650 0 4 _aDNA Repair Enzymes
_xantagonists & inhibitors
650 0 4 _aDacarbazine
_xanalogs & derivatives
650 0 4 _aGlioma
_xdrug therapy
650 0 4 _aGuanine
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aTemozolomide
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTumor Suppressor Proteins
_xantagonists & inhibitors
700 1 _aSchmidt, Olivia P
700 1 _aTriemer, Therese
700 1 _aLuedtke, Nathan W
773 0 _tChembiochem : a European journal of chemical biology
_gvol. 18
_gno. 10
_gp. 894-898
856 4 0 _uhttps://doi.org/10.1002/cbic.201600652
_zAvailable from publisher's website
999 _c26861554
_d26861554